A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
Alireza Mohebbi, Fahimeh Shahriyary, Vida Farrokhi, Bita Bandar, Najmaldin Saki
Topics & Concepts
MedicineVenetoclaxMyeloid leukemiaOncologyClinical trialInternal medicineCardiotoxicityDiseaseAdverse effectRefractory (planetary science)Systematic reviewChemotherapyIntensive care medicineLeukemiaMEDLINEChronic lymphocytic leukemiaLawAstrobiologyPhysicsPolitical scienceAcute Myeloid Leukemia ResearchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research